Get exclusive money-saving offers and guides
Straight to your inbox
By signing up, you agree to the Finder
Privacy & Cookies Policy
and
Terms of Use, Disclaimer & Privacy Policy.
Investments
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Pro Medicus Limited is a health information services business based in Australia. Pro Medicus shares (PME) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Pro Medicus has a trailing 12-month revenue of around $59.1 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Pro Medicus
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Pro Medicus. Find the share by name or ticker symbol: PME. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Pro Medicus reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Pro Medicus. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Finder Award
Our top pick for
Cheap broker fees
Finder Award
Our top pick for
Long-term investing
Finder Award
Pro Medicus share price
Use our graph to track the performance of PME stocks over time.Pro Medicus shares at a glance
Information last updated 2021-06-18.
| 52-week range | $22.3238 - $56.17 |
|---|---|
| 50-day moving average | $46.1939 |
| 200-day moving average | $41.9303 |
| Target price | $9.96 |
| PE ratio | 237.4894 |
| Dividend yield | $0.13 (0.24%) |
| Earnings per share (TTM) | $0.235 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Pro Medicus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Pro Medicus price performance over time
Historical closes compared with the last close of A$48.66
| 1 week (2021-06-17) | -10.07% |
|---|---|
| 1 month (2021-05-25) | 8.62% |
| 3 months (2021-03-24) | 11.38% |
| 6 months (2020-12-24) | 40.76% |
| 1 year (2020-06-24) | 76.62% |
|---|---|
| 2 years (2019-06-24) | 85.73% |
| 3 years (2018-06-22) | 566.58% |
| 5 years (2016-06-24) | 944.21% |
Is Pro Medicus under- or over-valued?
Valuing Pro Medicus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pro Medicus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pro Medicus's P/E ratio
Pro Medicus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 237x. In other words, Pro Medicus shares trade at around 237x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Pro Medicus's EBITDA
Pro Medicus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $34.2 million.
The EBITDA is a measure of a Pro Medicus's overall financial performance and is widely used to measure a its profitability.
Pro Medicus financials
| Revenue TTM | $59.1 million |
|---|---|
| Operating margin TTM | 57.41% |
| Gross profit TTM | $56.5 million |
| Return on assets TTM | 21.78% |
| Return on equity TTM | 39.88% |
| Profit margin | 41.55% |
| Book value | 0.68 |
| Market capitalisation | $5.8 billion |
TTM: trailing 12 months
Pro Medicus share dividends
Dividend payout ratio: 54.17% of net profits
Recently Pro Medicus has paid out, on average, around 54.17% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Pro Medicus shareholders could enjoy a 0.26% return on their shares, in the form of dividend payments. In Pro Medicus's case, that would currently equate to about A$0.13 per share.
Pro Medicus's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 3 March 2021 (the "ex-dividend date").
Pro Medicus share price volatility
Over the last 12 months, Pro Medicus's shares have ranged in value from as little as $22.3238 up to $56.17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Pro Medicus's is 0.3245. This would suggest that Pro Medicus's shares are less volatile than average (for this exchange).
Pro Medicus overview
Pro Medicus Limited provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions in Australia, Europe, and North America. It offers medical software for practice management; integration products; Promedicus.net secure email; healthcare software that provides radiologist and clinicians with advanced visualization capability for viewing 2-D, 3-D, and 4-D medical images; and PACS/Digital imaging software. The company offers its products under the Visage RIS, Visage RIS/PACS, and Visage 7 names. It also provides Visage Ease Pro, a mobile applications, which allow users access to medical imaging results that are stored on a Visage 7 server; training, installation, and professional services; and after sale support and service products. The company offers its products and services to hospitals, diagnostic imaging groups, and other health related entities. Pro Medicus Limited was founded in 1983 and is headquartered in Richmond, Australia.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
3 Virgin Australia sales to get you 50% off flights + 50% bonus points
Earn extra points for every $1 spent when you book these domestic flights before the end of the financial year.
-
Prime Day deal: $100 off Sony’s ‘Bose Killing’ Headphones
Get 33% off Sony WH1000XM3 Wireless Noise Cancelling Headphones during Amazon Prime Day 2021. Here's how to get the deal before it disappears.
-
Amazon Prime Day best book deals for all ages: Up to 55% off
Snap up best-selling reads for the whole family with these great Australian Prime Day offers.
-
The best Amazon Prime Day phone deals Australia: $600 off
Top offers include 57% off phone accessories, 38% off OPPO and 36% off Nokia.
-
Amazon Prime Day’s best appliance deals: 49% off De’Longhi, Philips
From air fryers to coffee makers to vacuum cleaners and more, these are the very best appliance deals that Amazon has to offer this Prime Day.
-
Amazon Prime Day: 75% off these massive beauty brands
Prime Day is your only chance to save big on Olaplex, Maybelline, La-Roche Posay, Calvin Klein fragrances and more.
-
Best Amazon Prime Day headphone deals: 58% off Sony + heaps more
Top headphone offers include 58% off Sony, 54% off Sennheiser and 45% off Bose.
-
Prime Day 2021: Up to 40% off tablets from Lenovo, Samsung and Huawei
Prime Day is here – don't miss your chance to save big on these tablets from your favourite tech brands.
-
Finder Daily Deals: The 5 best deals in Australia today
Today's best Finder Daily deals include: Amazon Prime Day 2021 deals, $270 off Sunbeam coffee machines, $70 off Xbox Series S.
-
The best Amazon Prime Day deals from Aussie brands: Get 45% off
Here are the Prime Day deals you can feel especially good about shopping.
Ask an Expert
